Progestin is a synthetic form of progesterone and is used in hormonal birth control and menstrual cycle. Progestin is available as oral tablets, intramuscular injections, and in solution forms. Progestin possess similar function to those of natural progesterone but they are structurally different. Generally, progestin is used in birth control pills globally. With the increase in prevalence of several cases of infertility treatment the synthetic progestin market is growing.
MARKET DYNAMICS
Factors driving the growth of the synthetic progestin market are growth in the incidences of amenorrhea, absence of menstrual periods, and rise in cases of infertility treatment. However, lack of awareness and severe side effects such as blurred vision and chest pain are likely to hamper the growth of the market. Moreover, infrastructure development in healthcare industry in the synthetic progestin is further likely to create growth opportunities in the market.
MARKET SCOPE
The "Synthetic Progestin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of synthetic progestin market with detailed market segmentation by type of vaccine, route of administration, and distribution channel. The synthetic progestin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in synthetic progestin market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The synthetic progestin market is segmented on the basis of type, and end use. On the basis of type, the market is categorized as oral type, injection type, suspended/gel type. On the basis of end use, the market is categorized as hospital, clinic, pharmacies & drug stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the synthetic progestin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The synthetic progestin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting synthetic progestin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the synthetic progestin market in these regions.
MARKET PLAYERS
The report covers key developments in the synthetic progestin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from synthetic progestin market are anticipated to have lucrative growth opportunities in the future with the rising demand for synthetic progestin in the global market. Below mentioned is the list of few companies engaged in the synthetic progestin market.
The report also includes the profiles of key players in synthetic progestin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
-Merck
-Teva Generics
-Zhejiang Xianju Pharmaceutical
-Zhejiang Aisheng Pharmaceutical
-Besins Healthcare
-Zhejiang Medicine
-Virtus Pharmaceuticals, LLC
-BionPharma
-Pfizer Inc.
-GlaxoSmithKline plc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.